| A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients (NCT00141661) | Pfizer | 2005-10-01 |
| Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease (NCT00183378) | University of Washington | 2005-09-01 |
| Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease (NCT00500500) | Ipsen | 2005-07-01 |
| Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients (NCT00110552) | Oregon Health and Science University | 2005-07-01 |
| Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach? (NCT00147693) | Radboud University Medical Center | 2005-06-01 |
| The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients (NCT00255086) | Stanford University | 2005-05-01 |
| An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period (NCT00299676) | Janssen-Cilag Pty Ltd | 2005-05-01 |
| Study of the Effect of SR57667B in Patients With Alzheimer's Disease (NCT00285025) | Sanofi | 2005-03-01 |
| Testing the Effectiveness of Telephone Support for Dementia Caregivers (NCT00119561) | US Department of Veterans Affairs | 2005-02-01 |
| Evaluating Simvastatin's Potential Role in Therapy (NCT00486044) | University of Wisconsin, Madison | 2005-02-01 |
| Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's (NCT00105547) | Myrexis Inc. | 2005-02-01 |
| The Chinese Familial Alzheimer's Network (NCT03657732) | Capital Medical University | 2005-01-10 |
| Life From Vision in Alzheimer Disease (NCT00838942) | Assistance Publique - Hôpitaux de Paris | 2004-12-01 |
| Couples Coping With Alzheimer's Disease (NCT00438724) | Alzheimer's Association | 2004-11-01 |
| Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease (NCT00911807) | Ever Neuro Pharma GmbH | 2004-10-01 |
| Antipsychotic Discontinuation in Alzheimer's Disease (NCT00417482) | New York State Psychiatric Institute | 2004-08-01 |
| Effect of Lithium and Divalproex in Alzheimer's Disease (NCT00088387) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-07-01 |
| A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease (NCT00297362) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2004-06-01 |
| Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease (NCT00088673) | Bellus Health Inc. - a GSK company | 2004-06-01 |
| PET Study of Acetylcholine Esterase Activity in Alzheimer's Disease (NCT06180252) | IRCCS San Raffaele | 2004-05-12 |
| PET Changes in Alzheimer's Disease (AD) (NCT00094913) | National Institute on Aging (NIA) | 2004-05-01 |
| Huperzine A in Alzheimer's Disease (NCT00083590) | National Institute on Aging (NIA) | 2004-04-01 |
| The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type (NCT00216515) | Janssen Korea, Ltd., Korea | 2004-03-01 |
| Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease (NCT00285077) | Sanofi | 2004-03-01 |
| A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease (NCT00645190) | Xian-Janssen Pharmaceutical Ltd. | 2004-03-01 |
| Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers (NCT00255866) | University of Washington | 2004-01-01 |
| Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study (NCT00076440) | Voyager Pharmaceutical Corporation | 2003-12-01 |
| Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study (NCT00216593) | Janssen Pharmaceutica N.V., Belgium | 2003-12-01 |
| Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT00104013) | Sanofi | 2003-11-01 |
| 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT00103649) | Sanofi | 2003-11-01 |
| Apathy Associated With Alzheimer's Disease (NCT00254033) | Sunnybrook Health Sciences Centre | 2003-10-01 |
| The Serotonergic Transmitter System in Dementia and Affective Disorders (NCT00192998) | Rigshospitalet, Denmark | 2003-10-01 |
| Valproate in Dementia (VALID) (NCT00071721) | Alzheimer's Disease Cooperative Study (ADCS) | 2003-10-01 |
| Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease (NCT00191009) | Eli Lilly and Company | 2003-10-01 |
| An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease (NCT00409279) | The Jacob and Valeria Langeloth Foundation | 2003-09-01 |
| Predictors of Cognitive Decline in Normal Aging (NCT00094939) | National Institute on Aging (NIA) | 2003-09-01 |
| A Comparison of Two Standard Therapies in the Management of Dementia With Agitation (NCT00208819) | Emory University | 2003-09-01 |
| The Dementia Study in Northern Norway (NCT00443014) | University Hospital of North Norway | 2003-06-01 |
| Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II (NCT00089882) | National Institute on Aging (NIA) | 2003-05-01 |
| ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (NCT00063310) | Voyager Pharmaceutical Corporation | 2003-03-01 |
| An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type (NCT00153010) | Boehringer Ingelheim | 2003-02-01 |
| Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II (NCT00059410) | Alzheimer's Association | 2003-01-01 |
| Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study (NCT00053599) | National Institute on Aging (NIA) | 2002-12-01 |
| A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 (NCT00165659) | Eisai Limited | 2002-11-01 |
| A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes (NCT00630851) | Pfizer | 2002-10-01 |
| Bathing Persons With Alzheimer's Disease aT Home (The BATH Study) (NCT00062569) | National Institute of Nursing Research (NINR) | 2002-09-01 |
| The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease (NCT00046358) | National Institute of Mental Health (NIMH) | 2002-09-01 |
| Alzheimer's Disease Genetics Study (NCT00064870) | Indiana University | 2002-06-01 |
| Coordinating Center for Caregiver Intervention Trial (NCT00177489) | University of Pittsburgh | 2002-06-01 |
| Brain Imaging in Alzheimer's Disease (NCT00039702) | National Institute of Mental Health (NIMH) | 2002-06-01 |
| Treatment for Early Memory Loss (NCT00042172) | University of Iowa | 2002-06-01 |
| Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) (NCT00040378) | Frederick Schmitt | 2002-05-01 |
| Vitamin E in Aging Persons With Down Syndrome (NCT00056329) | New York State Institute for Basic Research | 2002-04-01 |
| Pioglitazone in Alzheimer Disease (NCT00982202) | National Institute on Aging (NIA) | 2002-01-01 |
| Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder (NCT00029120) | National Institute of Mental Health (NIMH) | 2001-12-18 |
| Alzheimer's Disease: Therapeutic Potential of Estrogen (NCT00066157) | University of Wisconsin, Madison | 2001-09-01 |
| Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease (NCT00065767) | University of Wisconsin, Madison | 2001-09-01 |
| PET Study of the Nicotinic Receptors in Human (NCT00543322) | Commissariat A L'energie Atomique | 2001-07-01 |
| A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (NCT00236574) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-05-01 |
| A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (NCT00236431) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-05-01 |
| An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. (NCT00301574) | Janssen Pharmaceutical K.K. | 2001-04-01 |
| Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation (NCT00253214) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-03-01 |
| Alzheimer's in Long-Term Care--Treatment for Agitation (NCT00161473) | University of Washington | 2001-01-01 |
| COGNIShunt® System for Alzheimer's Disease (NCT00056628) | Eunoe | 2001-01-01 |
| Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) (NCT00007189) | Seattle Institute for Biomedical and Clinical Research | 2001-01-01 |
| Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease (NCT00034762) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-12-01 |
| Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs (NCT00065169) | University of California, Los Angeles | 2000-11-01 |
| Lipitor as a Treatment for Alzheimer's Disease (NCT00024531) | Institute for the Study of Aging (ISOA) | 2000-10-01 |
| Effect of Indomethacin on the Progression of Alzheimer's Disease (NCT00432081) | Radboud University Medical Center | 2000-05-01 |
| Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type (NCT00036114) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2000-03-01 |
| Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease (NCT00304629) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-03-01 |
| Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type (NCT00041678) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2000-01-01 |
| Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type (NCT02249351) | Boehringer Ingelheim | 1999-12-01 |
| Insulin, Neurogenetics and Memory in Alzheimer's Disease (NCT00018382) | US Department of Veterans Affairs | 1999-10-01 |
| Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease (NCT00006399) | National Center for Research Resources (NCRR) | 1999-09-01 |
| Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease (NCT00467766) | Pfizer | 1999-07-01 |
| Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type (NCT02248116) | Boehringer Ingelheim | 1999-05-01 |
| The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients (NCT00480870) | Associacao Fundo de Incentivo a Psicofarmcologia | 1999-04-01 |
| Memory Impairment Study (Mild Cognitive Impairment Study) (NCT00000173) | National Institute on Aging (NIA) | 1999-03-01 |
| Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type (NCT02249403) | Boehringer Ingelheim | 1999-01-01 |
| A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia (NCT00261573) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1998-12-01 |
| Electrophysiologic Measures of Treatment Response in Alzheimer Disease (NCT00018278) | US Department of Veterans Affairs | 1998-10-01 |
| A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia (NCT00249158) | Janssen-Cilag Pty Ltd | 1998-03-01 |
| A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease (NCT00253227) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-07-01 |
| A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease (NCT00253188) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-02-01 |
| Coordinating Center for Enhancing ADRD Caregiving (NCT00178165) | University of Pittsburgh | 1996-09-01 |
| Estrogen Hormone Protocol (NCT00000177) | National Institute on Aging (NIA) | 1995-10-01 |
| Serotonergic Pharmacotherapy for Agitation of Dementia (NCT00009204) | Bruce Pollock | 1995-09-01 |
| A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia (NCT00249145) | Janssen Pharmaceutica N.V., Belgium | 1995-04-01 |
| Expanded Access to Provide SUVN-502 for the Treatment of Subjects With Alzheimer's Disease (NCT03564964) | Suven Life Sciences Limited | |
| A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study) (NCT00004845) | National Institute on Aging (NIA) | |
| A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease (NCT00035204) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Multicenter Trial of Prednisone in Alzheimer's Disease (NCT00000178) | National Institute on Aging (NIA) | |
| Agitation in Alzheimer's Disease (NCT00000179) | National Institute on Aging (NIA) | |
| Using Hypnotherapy For Dementia & Alzheimer's (NCT01435551) | Families To The Rescue | |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia (NCT00253123) | Janssen, LP | |
| A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease (NCT00253201) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients (NCT00281749) | Maimonides Medical Center | |
| Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx) (NCT00000174) | Novartis | |
| Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease (NCT00013923) | National Institute on Aging (NIA) | |